0000950138-20-000310.txt : 20200804
0000950138-20-000310.hdr.sgml : 20200804
20200804161518
ACCESSION NUMBER: 0000950138-20-000310
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200803
FILED AS OF DATE: 20200804
DATE AS OF CHANGE: 20200804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: YOUNG TODD S.
CENTRAL INDEX KEY: 0001682584
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38661
FILM NUMBER: 201073474
MAIL ADDRESS:
STREET 1: C/O ACADIA PHARMACEUTICALS INC.
STREET 2: 3611 VALLEY CENTRE DRIVE, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elanco Animal Health Inc
CENTRAL INDEX KEY: 0001739104
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 825497352
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2500 INNOVATION WAY
CITY: GREENFIELD
STATE: IN
ZIP: 46140
BUSINESS PHONE: 877-352-6261
MAIL ADDRESS:
STREET 1: 2500 INNOVATION WAY
CITY: GREENFIELD
STATE: IN
ZIP: 46140
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2020-08-03
0001739104
Elanco Animal Health Inc
ELAN
0001682584
YOUNG TODD S.
C/O ELANCO ANIMAL HEALTH INCORPORATED
2500 INNOVATION WAY
GREENFIELD
IN
46140
0
1
0
0
See Remarks
Common Stock
41513
D
Common Stock
2020-08-03
4
P
0
2000
23.850
A
2000
I
by J. G. Young IRA
Common Stock
2020-08-03
4
P
0
5000
23.94
A
5000
I
by IRA
Tangible Equity Units
2020-08-03
4
P
0
1000
40.55
A
Common Stock
1562
1000
I
by IRA
Each 5.00% Tangible Equity Unit (TEU) includes a prepaid stock purchase contract that will automatically settle on February 1, 2023 (unless settled early at the holder's discretion) for between 1.3021 and 1.5625 shares of Elanco's common stock (subject to adjustment in certain circumstances), based upon the applicable market value of Elanco's common stock prior to settlement. The Reporting Person may elect to settle the purchase contracts prior to February 1, 2023 at the minimum settlement rate of 1.3021 shares of Elanco's common stock. Additionally the purchase contracts may be settled early by the Reporting Person or Elanco under certain circumstances described in the purchase contract.
Represents the maximum number of shares of Elanco's common stock initially issuable upon settlement of the purchase contract included in the TEUs based on the maximum settlement rate.
Executive Vice President and Chief Financial Officer
/s/ Darlene Quashie Henry, as Attorney-in-Fact for Todd S. Young
2020-08-04